Regulation Of Gasdermin D By Mir-379-5p Is Involved In Arsenite-Induced Activation Of Hepatic Stellate Cells And In Fibrosis Via Secretion Of Il-1 Beta From Human Hepatic Cells
Junjie Li,Junchao Xue,Dapeng Wang,Xiangyu Dai,Qian Sun,Tian Xiao,Lu Wu,Haibo Xia,Golam Mostofa,Xiong Chen,Yongyue Wei,Feng Chen,Quazi Quamruzzaman,Aihua Zhang,Qizhan Liu
DOI: https://doi.org/10.1039/c8mt00321a
2019-01-01
Metallomics
Abstract:Arsenic is an environmental toxicant and human carcinogen. The liver is the main site of arsenic storage and metabolism. Exposure to excessive arsenic causes liver damage and release of pro-inflammatory factors, which in turn lead to liver fibrosis. Gasdermin D (GSDMD), a mediator of pyroptosis, has low expression in hepatic tumor cells. In L-02 cells, arsenite caused increases of GSDMD and cleaved caspase-1 levels and decreases of caspase-1 and miR-379-5p levels. It also promoted the release of IL-1 beta in a concentration-and time-dependent manner. Luciferase reporter assays showed that GSDMD was a direct target of miR-379-5p. In L-02 cells, the over-expression of miR-379-5p blocked the arseniteinduced increases of GSDMD levels and the release of IL-1b, effects that were reversed by up-regulation of GSDMD. LX-2 cells, cultured in the media from arsenite-treated L-02 cells, showed elevated levels of proliferating cell nuclear antigen (PCNA), collagen I, vimentin, and alpha-smooth muscle actin (a-SMA), which indicated activation of these cells. Activation of LX-2 cells by media from arsenite-treated L-02 cells was inhibited by IL-1 beta neutralizing antibody. The media from arsenite-treated L-02 cells transfected with an miR-379-5p mimic inhibited the activation of LX-2 cells, a process that was reversed by up-regulation of GSDMD and by co-treatment with human recombinant IL-1 beta. Chronic exposure to arsenite induced, in liver tissue of mice, morphological damage, collagen deposition, and activation of hepatic stellate cells (HSCs). In liver tissue of arsenite-exposed mice, the levels of miR-379-5p were lower, but the levels of GSDMD and cleaved caspase-1 were elevated, and in sera from arsenite-exposed mice, the IL-1 beta levels were elevated. These results indicate that, by elevating the secretion of IL-1b, miR-379-5p regulation of GSDMD is involved in arsenite-induced activation of HSCs and in hepatic fibrosis. This establishes a previously unknown molecular mechanism for arsenite-induced liver damage, inflammation, and fibrosis.